<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To analyze the relationship between diabetics and the <z:hpo ids='HP_0003674'>onset</z:hpo>, clinical outcomes and prognosis of <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e>, and to evaluate the impact of <z:mp ids='MP_0002055'>diabetes</z:mp> on <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHOD: Compare 172 cases of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> in patients with or without <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Analyze the associated risk factors of patients with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brain-stem infarction</z:e> in diabetics by multi-variate logistic regression analysis </plain></SENT>
<SENT sid="3" pm="."><plain>Compare the National Institutes of Health <z:hpo ids='HP_0001297'>Stroke</z:hpo> Scale (NIHSS) and Modified Rankin scale (mRS) Score, pathogenetic condition and the outcome of the two groups in different times </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The systolic blood pressure (SBP), TG, <z:chebi fb="0" ids="47774">LDL-C</z:chebi>, <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (Apo B), <z:chebi fb="0" ids="32483">glutamyl</z:chebi> transpeptidase (γ-GT), fibrinogen (Fb), fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (FPG) and glycosylated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>(HbA1c)in diabetic group were higher than those in non-diabetic group, which was statistically significant (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>From multi-variate logistic regression analysis, γ-GT, Apo B and FPG were the risk predictors of <z:mp ids='MP_0002055'>diabetes</z:mp> with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e>(OR = 1.017, 4.667 and 3.173, respectively), while <z:chebi fb="0" ids="47775">HDL-C</z:chebi> was protective (OR = 0.288) </plain></SENT>
<SENT sid="6" pm="."><plain>HbA1c was a risk predictor of severity for <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> (OR = 1.299), while Apo A was beneficial (OR = 0.212) </plain></SENT>
<SENT sid="7" pm="."><plain>Compared with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brain-stem infarction</z:e> in non-diabetic group, NIHSS score and intensive care therapy of diabetic groups on the admission had no statistically significance, while the NIHSS score on discharge and the outcome at 6 months' of follow-up were statistically significant </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: <z:mp ids='MP_0002055'>Diabetes</z:mp> is closely associated with <z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">brainstem infarction</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0521542" disease_type="Disease or Syndrome" abbrv="">Brainstem infarction</z:e> with <z:mp ids='MP_0002055'>diabetes</z:mp> cause more <z:hpo ids='HP_0003678'>rapid progression</z:hpo>, poorer prognosis, higher rates of mortality as well as disability and higher recurrence rate of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>